Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iPrEx: FTC/TDF for HIV Prevention in Men
NCT00458393Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jun 2007
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Started Jun 2007; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00458393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00458393.